BAYERCROP3,979.20

Bayer Cropscience Ltd.

· Chemicals
₹ CrorePeersUPLPIINDRALLISATULSHKANURASCAMLINFINECLEAN
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation74.094.0
+ Finance Costs19.619.8
+ Interest Income-40.5-32.5
Changes in Working Capital
+ Inventories207.2199.9
+ Trade Receivables — Current12.9-196.2
+ Trade Payables — Current-268.1139.5
Cash from Operating Activities
Profit Before Tax (per I/S)941.4707.4854.9
Cash from Operations (pre-tax)1,083.71,242.0
+ Income Taxes Paid132.1163.5
Cash from Operating Activities951.61,078.5
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)45.739.9
+ Sale of Investments (Equity / Debt)1.78.3
+ Interest Received — Investing30.431.1
Cash from Investing Activities0.472.5
Cash from Financing Activities
+ Payment of Lease Liabilities41.8
+ Interest Paid7.812.8
+ Dividends Paid562.8
Cash from Financing Activities-656.3-623.8
Net Changes in Cash295.7527.2
Closing Cash1,156.51,412.7
Reference Items
EBITDA954.0689.6873.7
EBITDA Margin %18.6912.6015.40
Free Cash Flow (CFO − Capex)905.91,038.6
Cash Flow to Net Income1.291.56
Cash Paid for Taxes132.1163.5
Cash Paid for Interest7.812.8
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.